Human papillomavirus vaccine in adolescent women: a 2012 update : Current Opinion in Obstetrics and Gynecology

Secondary Logo

Journal Logo


Human papillomavirus vaccine in adolescent women

a 2012 update

Etter, Dillon J.; Zimet, Gregory D.; Rickert, Vaughn I.

Author Information
Current Opinion in Obstetrics and Gynecology 24(5):p 305-310, October 2012. | DOI: 10.1097/GCO.0b013e3283567005


Purpose of review 

Despite recommendations from the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents with the human papillomavirus (HPV) vaccine, U.S. coverage among women remains less than 50%, with that of adolescent men below 2%.

Recent findings 

Ongoing studies document the efficacy and safety of the HPV vaccine. Nevertheless, misconceptions and negative attitudes persist and serve as barriers to vaccine uptake. Additionally, other factors such as age, insurance status, poverty status, and racial or ethnic background have been associated with diminished vaccine uptake and poor completion rates. Internationally, HPV vaccination programs and school-based programs have achieved increased rates of uptake and series completion. HPV vaccination coverage may also be facilitated by improving communication between physicians, parents, and adolescents as well as by addressing common misconceptions about the vaccine.


This review highlights significant findings of recent literature on HPV vaccination of adolescent women with a special focus on uptake, series completion, communication, disparities in vaccine coverage, and other health outcomes associated with HPV vaccination.

© 2012 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid